Virotherapy
Virotherapy
Select locations
Select company type
Select type
Select industries
Select industry
Number of employees
Min.
Max.
Founding year
Lock keywords
Exclude keywords
Define optional keywords
Virotherapy is a type of therapy that uses viruses to treat and combat disease. It involves introducing a harmless virus into the body to infect and destroy diseased cells, while leaving healthy cells unharmed. Virotherapy is a promising treatment for a variety of diseases, including cancer, HIV, and some infectious diseases.
... Oncolytic virotherapy is a form of cancer treatment that involves the use of viruses to selectively infect and kill cancer cells. It has several potential benefits as a treatment option for cancer. ...
... to once per month. The patient is being monitored by an ophthalmologist. She is stable with the virotherapy ongoing and magnetic resonance cholangiopancreatography (7 May 2018) and abdominal ultrasound (23 March 2019) imaging excludes metastasis formation. The quality of life is high. ...
... Oncolytic Virotherapy Oncolytic viruses (OVs) are designed to directly kill tumor cells and induce an anti-tumor immune response. However, the clinical benefit of existing OVs remains limited, due to the inability to improve overall survival for patients. Virogin aims to engineer the viral ...
... Contract Research, Therapeutics, Oncolytic Virotherapy, CRISPR, Genetic Circuits, Yeast and Mammalian Expression Systems, High-Copy Plasmids, Synthetic Biology, Custom Services ...
... Ab A1801 ADC PMB-104 PMB-107 PBI-108 Recombinant Protein Therapy P75NEURO Ultra-Long-Acting GLP-1 Analogue Angiocidin TT-173 Oncolytic Virotherapy RV-scFv-PDL1 OV-FV-01 Small Molecules Polyoxygenated Cyclohexene Compound 4 Fascin Inhibitor KCNQ2/3 Potassium Channel Opener HBV Capsid ...
... Calidi Biotherapeutics Announces Exclusive License Agreement with City of Hope and the University of Chicago for Novel Oncolytic Virotherapy Technology - Calidi ...
... Calidi Biotherapeutics Announces Presentation at 6th Annual Oncolytic Virotherapy Summit - Calidi ...
... Oncolytic Virotherapy Summit - ...
... Oncolytic Virotherapy Summit - ...
... Nettlebeck et al. (2021) Virotherapy in Germany – recent activities in virus engineering, preclinical development, and clinical studies. ...
... Nettlebeck et al. (2021) Virotherapy in Germany – recent activities in virus engineering, preclinical development, and clinical studies. ...
... Semireplication-competent vesicular stomatitis virus as a novel platform for oncolytic virotherapy. J Mol Med (Berl), 90(8):959-70 (2012) ...
... Chemovirotherapy: combining chemotherapeutic treatment with oncolytic virotherapy Oncolytic Virother. 2015; 4: 39–48. Eike Binz, Ulrich M Lauer > Full ...
... DPS Group Selected by Vibalogics to Design Virotherapy Manufacturing Facility — DPS Group | Better Engineered Solutions — Vibalogics, a global contract development and manufacturing organization (CDMO), selected DPS to design a new, 110,000 SF late-phase clinical and commercial manufacturing ...
